An Antimicrobial Treatment Assessment of Serratia marcescens Bacteremia and Endocarditis
Douglas Slain1, Catessa Howard2, C Garret Cooper3
1Department of Clinical Pharmacy, School of Pharmacy, Section of Infectious Diseases, School of Medicine, West Virginia University, Morgantown, WV, United States.
Abstract:
We assessed the treatment of Serratia marcescens bacteremia and endocarditis in one of the largest single center studies. We could not identify an advantage with any particular antibiotic treatment regimen in this study. Induction of AmpC or selection of ESBL organisms was not displayed by any of the organisms.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Clinical Significance of Antibiotic Resistance


